BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34204365)

  • 1. Unique Polymorphisms at
    Akbulut-Jeradi N; Fernandez MJ; Al Khaldi R; Sukumaran J; Adekile A
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
    PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of BCL11A and HBS1L-MYB Genotypes in Sickle Cell Anemia.
    Qadah T; Noorwali A; Alzahrani F; Banjar A; Filimban N; Felimban R
    Indian J Hematol Blood Transfus; 2020 Oct; 36(4):705-710. PubMed ID: 33100714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
    Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
    Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
    Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.
    Manu GP; Segbefia C; N'guessan BB; Coffie SA; Adjei GO
    Pharmgenomics Pers Med; 2022; 15():205-214. PubMed ID: 35300055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach.
    Fanis P; Kousiappa I; Phylactides M; Kleanthous M
    BMC Genomics; 2014 Feb; 15():108. PubMed ID: 24502199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients.
    Razak SAA; Murad NAA; Masra F; Chong DLS; Abdullah N; Jalil N; Alauddin H; Sabudin RZAR; Ithnin A; Khai LC; Aziz NA; Muda Z; Ibrahim H; Latiff ZA
    Curr Mol Med; 2018; 18(5):295-305. PubMed ID: 30289070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
    Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
    Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existence of HbF Enhancer Haplotypes at
    Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
    Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
    [No Abstract]   [Full Text] [Related]  

  • 14. Single Nucleotide Polymorphisms in
    Mohammad SNNA; Iberahim S; Wan Ab Rahman WS; Hassan MN; Edinur HA; Azlan M; Zulkafli Z
    Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variant in the BCL11A (rs1427407), but not HBS1-MYB (rs6934903) loci associate with fetal hemoglobin levels in Indian sickle cell disease patients.
    Bhanushali AA; Patra PK; Nair D; Verma H; Das BR
    Blood Cells Mol Dis; 2015 Jan; 54(1):4-8. PubMed ID: 25457385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia.
    Adeyemo TA; Ojewunmi OO; Oyetunji IA; Rooks H; Rees DC; Akinsulie AO; Akanmu AS; Thein SL; Menzel S
    PLoS One; 2018; 13(6):e0197927. PubMed ID: 29879141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
    Menzel S; Thein SL
    Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
    Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
    Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.